ADVERTISEMENT

Conference Report

IDWeek 2021 — Tenofovir disoproxil fumarate linked to weight loss in HIV-negative individuals on PrEP

Pavankumar Kamat   |   07 October 2021

Takeaway

  • Tenofovir disoproxil fumarate (TDF) for pre-exposure prophylaxis (PrEP) may be associated with weight loss in HIV-negative individuals.

Why this matters

  • There is evidence of weight gain associated with newer antiretrovirals, especially integrase inhibitors; however, it remains unclear how PrEP regimens with a nucleoside reverse transcriptase inhibitor backbone such as...

          

November Challenge

Ends in 1d 7h
left
right

Topic Challenges

left
right